表紙
市場調查報告書
商品編碼
1028893

Filgrastim生物相似藥的全球市場 (2021年) - COVID-19造成的成長和變化 (2030年)

Filgrastim Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球Filgrastim生物相似藥市場相關調查分析,提供市場特徵,市場規模與成長率,市場區隔,各地區·各國明細,競爭情形,市場佔有率,趨勢與策略相關的系統性資訊。

目錄

第1章 摘要整理

第2章 Filgrastim生物相似藥市場特徵

第3章 Filgrastim生物相似藥市場趨勢與策略

第4章 COVID-19對Filgrastim生物相似藥的影響

第5章 Filgrastim生物相似藥的市場規模與成長率

  • 全球Filgrastim生物相似藥市場實際成果 (金額)
  • 全球Filgrastim生物相似藥市場預測 (金額)

第6章 Filgrastim生物相似藥市場區隔

  • 全球Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 腫瘤
  • 慢性疾病·自體免疫疾病
  • 血液疾病
  • 生長激素缺乏症
  • 感染疾病
  • 其他
  • 全球Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)
  • 醫院藥局
  • 零售藥局
  • 線上藥局
  • 全球Filgrastim生物相似藥市場:各製造類型,實際成果與預測 (金額)
  • 公司內部製造
  • CMO

第7章 Filgrastim生物相似藥市場各地區·各國分析

  • 全球Filgrastim生物相似藥市場:各地區,實際成果與預測 (金額)
  • 全球Filgrastim生物相似藥市場:各國,實際成果與預測 (金額)

第8章 亞太地區的Filgrastim生物相似藥市場

  • 亞太地區的Filgrastim生物相似藥市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,課稅,公司稅結構,投資,主要企業
  • 亞太地區的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 亞太地區的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第9章 中國的Filgrastim生物相似藥市場

  • 中國的Filgrastim生物相似藥市場概要
  • 中國的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 中國的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第10章 印度的Filgrastim生物相似藥市場

  • 印度的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 印度的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第11章 日本的Filgrastim生物相似藥市場

  • 日本的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 日本的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第12章 澳洲的Filgrastim生物相似藥市場

  • 澳洲的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 澳洲的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第13章 印尼的Filgrastim生物相似藥市場

  • 印尼的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 印尼的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第14章 韓國的Filgrastim生物相似藥市場

  • 韓國的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 韓國的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第15章 西歐的Filgrastim生物相似藥市場

  • 西歐的Filgrastim生物相似藥市場概要
  • 西歐的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 西歐的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第16章 英國的Filgrastim生物相似藥市場

  • 英國的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 英國的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第17章 德國的Filgrastim生物相似藥市場

  • 德國的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 德國的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第18章 法國的Filgrastim生物相似藥市場

  • 法國的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 法國的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第19章 東歐的Filgrastim生物相似藥市場

  • 東歐的Filgrastim生物相似藥市場概要
  • 東歐的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 東歐的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第20章 俄羅斯的Filgrastim生物相似藥市場

  • 俄羅斯的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 俄羅斯的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第21章 北美的Filgrastim生物相似藥市場

  • 北美的Filgrastim生物相似藥市場概要
  • 北美的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 北美的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第22章 美國的Filgrastim生物相似藥市場

  • 美國的Filgrastim生物相似藥市場概要
  • 美國的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 美國的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第23章 南美的Filgrastim生物相似藥市場

  • 南美的Filgrastim生物相似藥市場概要
  • 南美的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 南美的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第24章 巴西的Filgrastim生物相似藥市場

  • 巴西的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 巴西的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第25章 中東的Filgrastim生物相似藥市場

  • 中東的Filgrastim生物相似藥市場概要
  • 中東的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 中東的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第26章 非洲的Filgrastim生物相似藥市場

  • 非洲的Filgrastim生物相似藥市場概要
  • 非洲的Filgrastim生物相似藥市場:各適應症,實際成果與預測 (金額)
  • 非洲的Filgrastim生物相似藥市場:各流通管道,實際成果與預測 (金額)

第27章 Filgrastim生物相似藥市場競爭情形和企業簡介

  • Filgrastim生物相似藥市場競爭情形
  • Filgrastim生物相似藥市場企業簡介
    • Cadila Pharmaceuticals
    • Dr. Reddy's Laboratories
    • Intas Biopharmaceuticals
    • Sandoz
    • Amgen Inc.

第28章 Filgrastim生物相似藥的開發平台分析

第29章 Filgrastim生物相似藥市場上主要的收購與合併

第30章 Filgrastim生物相似藥市場未來發展預測與潛在性分析

第31章 附錄

目錄
Product Code: h917

Filgrastim Biosimilars Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global filgrastim biosimilars market market.

This report focuses on filgrastim biosimilars market market which is experiencing strong growth. The report gives a guide to the filgrastim biosimilars market market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the filgrastim biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Filgrastim Biosimilars Market market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider filgrastim biosimilars market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The filgrastim biosimilars market market section of the report gives context. It compares the filgrastim biosimilars market market with other segments of the filgrastim biosimilars market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, filgrastim biosimilars market indicators comparison.

Scope

Markets Covered: 1) By Application: Oncology; Chronic And Autoimmune Diseases; Blood Disorders; Growth Hormone Deficiency; Infectious Diseases; Others

2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

3) By Type Of Manufacturing: In-House Manufacturing; Contract Manufacturing Oraganization

Companies Mentioned: Cadila Pharmaceuticals; Dr. Reddy's Laboratories; Intas Biopharmaceuticals; Sandoz; Amgen Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Filgrastim Biosimilars Market Characteristics

3. Filgrastim Biosimilars Market Trends And Strategies

4. Impact Of COVID-19 On Filgrastim Biosimilars

5. Filgrastim Biosimilars Market Size And Growth

  • 5.1. Global Filgrastim Biosimilars Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Filgrastim Biosimilars Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Filgrastim Biosimilars Market Segmentation

  • 6.1. Global Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oncology
  • Chronic and Autoimmune Diseases
  • Blood Disorders
  • Growth Hormone Deficiency
  • Infectious Diseases
  • Others
  • 6.2. Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • 6.3. Global Filgrastim Biosimilars Market, Segmentation By Type of Manufacturing, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • In-House Manufacturing
  • Contract Manufacturing Oraganization

7. Filgrastim Biosimilars Market Regional And Country Analysis

  • 7.1. Global Filgrastim Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Filgrastim Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Filgrastim Biosimilars Market

  • 8.1. Asia-Pacific Filgrastim Biosimilars Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Filgrastim Biosimilars Market

  • 9.1. China Filgrastim Biosimilars Market Overview
  • 9.2. China Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Filgrastim Biosimilars Market

  • 10.1. India Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Filgrastim Biosimilars Market

  • 11.1. Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Filgrastim Biosimilars Market

  • 12.1. Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Filgrastim Biosimilars Market

  • 13.1. Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Filgrastim Biosimilars Market

  • 14.1. South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Filgrastim Biosimilars Market

  • 15.1. Western Europe Filgrastim Biosimilars Market Overview
  • 15.2. Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Filgrastim Biosimilars Market

  • 16.1. UK Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Filgrastim Biosimilars Market

  • 17.1. Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Filgrastim Biosimilars Market

  • 18.4. France Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Filgrastim Biosimilars Market

  • 19.1. Eastern Europe Filgrastim Biosimilars Market Overview
  • 19.2. Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Filgrastim Biosimilars Market

  • 20.1. Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Filgrastim Biosimilars Market

  • 21.1. North America Filgrastim Biosimilars Market Overview
  • 21.2. North America Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Filgrastim Biosimilars Market

  • 22.1. USA Filgrastim Biosimilars Market Overview
  • 22.2. USA Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Filgrastim Biosimilars Market

  • 23.1. South America Filgrastim Biosimilars Market Overview
  • 23.2. South America Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Filgrastim Biosimilars Market

  • 24.1. Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Filgrastim Biosimilars Market

  • 25.1. Middle East Filgrastim Biosimilars Market Overview
  • 25.2. Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Filgrastim Biosimilars Market

  • 26.1. Africa Filgrastim Biosimilars Market Overview
  • 26.2. Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Filgrastim Biosimilars Market Competitive Landscape And Company Profiles

  • 27.1. Filgrastim Biosimilars Market Competitive Landscape
  • 27.2. Filgrastim Biosimilars Market Company Profiles
    • 27.2.1. Cadila Pharmaceuticals
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Dr. Reddy's Laboratories
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Intas Biopharmaceuticals
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Sandoz
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Amgen Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Filgrastim Biosimilars Pipeline Analysis

29. Key Mergers And Acquisitions In The Filgrastim Biosimilars Market

30. Filgrastim Biosimilars Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer